The Role of Imaging of Lymphatic System to Prevent Cancer Related Lymphedema

Bioengineering (Basel). 2023 Dec 10;10(12):1407. doi: 10.3390/bioengineering10121407.

Abstract

Lymphedema is a progressive chronic condition affecting approximately 250 million people worldwide, a number that is currently underestimated. In Western countries, the most common form of lymphedema of the extremities is cancer-related and less radical surgical intervention is the main option to prevent it. Standardized protocols in the areas of diagnosis, staging and treatment are strongly required to address this issue. The aim of this study is to review the main diagnostic methods, comparing new emerging procedures to lymphoscintigraphy, considered as the golden standard to date. The roles of Magnetic Resonance Lymphangiography (MRL) or indocyanine green ICG lymphography are particularly reviewed in order to evaluate diagnostic accuracy, potential associations with lymphoscintigraphy, and future directions guided by AI protocols. The use of imaging to treat lymphedema has benefited from new techniques in the area of lymphatic vessels anatomy; these perspectives have become of value in many clinical scenarios to prevent cancer-related lymphedema.

Keywords: ARM; MRL; imaging; lymphangiography; lymphedema; lymphoscintigraphy.

Publication types

  • Review

Grants and funding

This research received no external funding.